Literature DB >> 17078006

Efficacy of probiotics and nutrients in functional gastrointestinal disorders: a preliminary clinical trial.

Linda S Kim1, Lisa Hilli, Jennifer Orlowski, Jami L Kupperman, Matthew Baral, Robert F Waters.   

Abstract

The purpose of this study was to evaluate the efficacy and safety of commonly used probiotics and nutrients available for functional gastrointestinal disorders (FGID). Five different combinations of probiotics and nutrients, or placebo, were taken daily over 12 weeks. In this randomized controlled clinical trial, men and women 21 to 72 years of age with FGID symptoms of indigestion, bloating, and abdominal discomfort were assigned to one of six groups, 12 patients per group. Gastrointestinal Quality of Life Index (GIQLI) and visual analogue scale (VAS) for GI symptoms, SF-36, lactulose and mannitol test (LMT), and urine indican levels were evaluated. GIQLI, VAS scores, and LMT did not change significantly (P > 0.05). There were clinically notable improvements in two of the combination formulations. While the nonsignificant improvements in GI symptoms could suggest that combination probiotics and nutrients may be beneficial in conditions such as FGID, no conclusive evidence was found in this pilot trial. Further investigations to explore the findings are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17078006     DOI: 10.1007/s10620-006-9297-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  69 in total

1.  Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders.

Authors:  N T Hoa; L Baccigalupi; A Huxham; A Smertenko; P H Van; S Ammendola; E Ricca; A S Cutting
Journal:  Appl Environ Microbiol       Date:  2000-12       Impact factor: 4.792

Review 2.  Probiotics: what are they? What are their effects on gut physiology?

Authors:  Jean Fioramonti; Vassilia Theodorou; Lionel Bueno
Journal:  Best Pract Res Clin Gastroenterol       Date:  2003-10       Impact factor: 3.043

Review 3.  Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stepánková; Tomás Hudcovic; Ludmila Tucková; Bozena Cukrowska; Rája Lodinová-Zádníková; Hana Kozáková; Pavel Rossmann; Jirina Bártová; Dan Sokol; David P Funda; Dana Borovská; Zuzana Reháková; Jirí Sinkora; Jaroslav Hofman; Pavel Drastich; Alena Kokesová
Journal:  Immunol Lett       Date:  2004-05-15       Impact factor: 3.685

Review 4.  Probiotic use in children.

Authors:  Rosemary J Young; Shari Huffman
Journal:  J Pediatr Health Care       Date:  2003 Nov-Dec       Impact factor: 1.812

Review 5.  Clinical implications of the sugar absorption test: intestinal permeability test to assess mucosal barrier function.

Authors:  J J Uil; R M van Elburg; F M van Overbeek; C J Mulder; G P VanBerge-Henegouwen; H S Heymans
Journal:  Scand J Gastroenterol Suppl       Date:  1997

Review 6.  Inventing probiotic functional foods for patients with allergic disease.

Authors:  Kirsi Laiho; Arthur Ouwehand; Seppo Salminen; Erika Isolauri
Journal:  Ann Allergy Asthma Immunol       Date:  2002-12       Impact factor: 6.347

7.  Sorption of polycyclic aromatic compounds to humic and fulvic acid HPLC column materials.

Authors:  K Kollist-Siigur; T Nielsen; C Grøn; P E Hansen; C Helweg; K E Jonassen; O Jørgensen; U Kirso
Journal:  J Environ Qual       Date:  2001 Mar-Apr       Impact factor: 2.751

Review 8.  Probiotics and medical nutrition therapy.

Authors:  Amy C Brown; Ana Valiere
Journal:  Nutr Clin Care       Date:  2004 Apr-Jun

9.  Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS).

Authors:  Anne Damiano; Kathleen Handley; Ellen Adler; Reshmi Siddique; Ashoke Bhattacharyja
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

Review 10.  Gastrointestinal allergy to food: a review.

Authors:  T Ahmed; G J Fuchs
Journal:  J Diarrhoeal Dis Res       Date:  1997-12
View more
  8 in total

Review 1.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

2.  Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial.

Authors:  Mengli Xiao; Linda L D Zhong; Wai Ching Lam; Yingpan Zhao; Kok-Ann Gwee; Gerald Holtmann; Jan Tack; Hidekazu Suzuki; Min-Hu Chen; Yinglian Xiao; Xiaohua Hou; Jinsong Liu; Yang Li; Xu-Dong Tang; Fang Lu
Journal:  Trials       Date:  2022-06-02       Impact factor: 2.728

Review 3.  What is the evidence for the use of probiotics in functional disorders?

Authors:  Eamonn M M Quigley
Journal:  Curr Gastroenterol Rep       Date:  2008-08

4.  Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus.

Authors:  A P S Hungin; C R Mitchell; P Whorwell; C Mulligan; O Cole; L Agréus; P Fracasso; C Lionis; J Mendive; J-M Philippart de Foy; B Seifert; K-A Wensaas; C Winchester; N de Wit
Journal:  Aliment Pharmacol Ther       Date:  2018-02-20       Impact factor: 8.171

Review 5.  Therapeutic Potential of Fulvic Acid in Chronic Inflammatory Diseases and Diabetes.

Authors:  John Winkler; Sanjoy Ghosh
Journal:  J Diabetes Res       Date:  2018-09-10       Impact factor: 4.011

6.  Gastroesophageal Reflux Disease and Probiotics: A Systematic Review.

Authors:  Jing Cheng; Arthur C Ouwehand
Journal:  Nutrients       Date:  2020-01-02       Impact factor: 5.717

Review 7.  Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide.

Authors:  A P S Hungin; C Mulligan; B Pot; P Whorwell; L Agréus; P Fracasso; C Lionis; J Mendive; J-M Philippart de Foy; G Rubin; C Winchester; N de Wit
Journal:  Aliment Pharmacol Ther       Date:  2013-08-27       Impact factor: 8.171

8.  Efficacy of prebiotics and probiotics for functional dyspepsia: A systematic review and meta-analysis.

Authors:  Jiaqi Zhang; Hao Meng Wu; Xue Wang; Jingyi Xie; Xia Li; Jinxin Ma; Fengyun Wang; Xudong Tang
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.